home / stock / scyx / scyx short
Short Information | SCYNEXIS Inc. (NASDAQ:SCYX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 752,105 |
Total Actual Volume | 4,398,619 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 37,605 |
Average Short Percentage | 19.64% |
Is there a SCYX Short Squeeze or Breakout about to happen?
See the SCYX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-27-2024 | $1.41 | $1.425 | $1.46 | $1.4 | 107,777 | 32,233 | 29.91% |
03-26-2024 | $1.46 | $1.39 | $1.46 | $1.39 | 82,857 | 8,792 | 10.61% |
03-25-2024 | $1.39 | $1.43 | $1.46 | $1.39 | 146,830 | 9,344 | 6.36% |
03-22-2024 | $1.39 | $1.39 | $1.4112 | $1.38 | 72,439 | 15,327 | 21.16% |
03-21-2024 | $1.43 | $1.4 | $1.47 | $1.37 | 150,876 | 33,616 | 22.28% |
03-20-2024 | $1.45 | $1.41 | $1.49 | $1.39 | 336,264 | 68,392 | 20.34% |
03-19-2024 | $1.43 | $1.44 | $1.53 | $1.35 | 720,519 | 18,853 | 2.62% |
03-18-2024 | $1.48 | $1.44 | $1.52 | $1.3901 | 335,444 | 50,715 | 15.12% |
03-15-2024 | $1.51 | $1.45 | $1.55 | $1.45 | 366,714 | 75,536 | 20.6% |
03-14-2024 | $1.5 | $1.5 | $1.51 | $1.47 | 157,764 | 23,067 | 14.62% |
03-13-2024 | $1.57 | $1.53 | $1.601 | $1.5 | 285,492 | 55,722 | 19.52% |
03-12-2024 | $1.64 | $1.6 | $1.64 | $1.51 | 419,626 | 70,768 | 16.86% |
03-11-2024 | $1.64 | $1.61 | $1.68 | $1.59 | 184,919 | 39,289 | 21.25% |
03-08-2024 | $1.7 | $1.66 | $1.748 | $1.65 | 70,365 | 11,768 | 16.72% |
03-07-2024 | $1.68 | $1.69 | $1.6999 | $1.66 | 86,611 | 10,094 | 11.65% |
03-06-2024 | $1.67 | $1.67 | $1.68 | $1.6212 | 64,828 | 29,462 | 45.45% |
03-05-2024 | $1.63 | $1.65 | $1.68 | $1.5601 | 198,435 | 42,451 | 21.39% |
03-04-2024 | $1.63 | $1.63 | $1.65 | $1.57 | 233,803 | 57,094 | 24.42% |
03-01-2024 | $1.63 | $1.62 | $1.6699 | $1.6 | 212,585 | 62,869 | 29.57% |
02-29-2024 | $1.7 | $1.62 | $1.74 | $1.62 | 164,471 | 36,713 | 22.32% |
News, Short Squeeze, Breakout and More Instantly...
JERSEY CITY, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to ov...
JERSEY CITY, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced David Angulo, M.D., President and Chief Executive Officer, will pre...
In vivo data demonstrated response rate for oral SCY-247 similar to current standard of care, intravenous Liposomal Amphotericin B, for the treatment of mucormycosis Combination of SCY-247 and Liposomal Amphotericin B showed significant enhancement in survival and reduction in fungal burd...